Stockholm
,
Sweden
11 - 14 June 2026
European Hematology Association - 31st Congress, 2026 (EHA)
Presentation schedule and materials
Friday, 12 June 2026
18:45
- 19:45
CEST
PF1275
POSTER
Relative contribution of vaso-occlusive crises and non-crisis symptoms to daily disease burden in adults with sickle cell disease: regional analysis from the global listen survey
Johnny Mahlangu1, Shashidhar Rao2, Rohan Kolla2, Emma Tan2, Biree Andemariam3
MATERIALS AVAILABLE
Coming soon
Saturday, 13 June 2026
17:15
- 17:30
CEST
S295
ORAL PRESENTATION
Efficacy and safety of oral tetrahydrouridine-decitabine (NDec) in adults with sickle cell disease: results from the phase 2, global, randomized, parallel-group ASCENT1 trial
Biree Andemariam1; Priyanka Samal2; Dharmesh Vaghasiya3; Modupe Idowu4; Pernille Højlund Jacobsen5; Christian Jakob Carlsson5; Raffaella Colombatti6
MATERIALS AVAILABLE
Coming soon
17:45
- 18:00
CEST
S297
ORAL PRESENTATION
Etavopivat improves hemoglobin levels in adults and adolescents with non-transfusion-dependent α- or β-thalassemia: results from the open label phase 2 gladiolus study
Sujit Sheth1; Kevin H. M. Kuo2, 3; Theodosia A. Kalfa4; D. Mark Layton5; Perla Eleftheriou6; Anastasios Giakoumis7; Olga Polyanskaya8; Navid Nedjatian9; Ashutosh Lal10
MATERIALS AVAILABLE
Coming soon
18:15
- 18:30
CEST
S299
ORAL PRESENTATION
Etavopivat reduces transfusion requirements in adults and adolescents with transfusion-dependent α- or β-thalassemia: results from the open label phase 2 gladiolus study
Ashutosh Lal1; Saranya Veluswamy2; Melanie Kirby-Allen3; Yves Pastore4; Janet Kwiatkowski5; Leila Jerome Clay6; Olga Polyanskaya7; Navid Nedjatian8; Ali T. Taher9
MATERIALS AVAILABLE
Coming soon
Sunday, 14 June 2026
11:00
- 11:15
CEST
S290
ORAL PRESENTATION
Phase 1/2 hibiscus kids study of etavopivat in pediatric patients with sickle cell disease: safety and efficacy findings from the complete first cohort
Bernhards Ogutu1, 2; Miguel R. Abboud3; Subarna Chakravorty4; Iheanyi Okpala5; Pavithra Dhayakar6; Leila
Jerome Clay7; Kaming Lo 8; Adlette Inati9, 10
MATERIALS AVAILABLE
Coming soon
Keywords